HepG2 cell에서 유리지방산 유발 지방독성에 대한 生肝健脾湯과 일부 조성 한약물의 효과

키워드

참고문헌 (38)

1. van Herpen NA, "Lipid accumulation in non-adipose tissue and lipotoxicity", Physiol Behav, 94, pp.231~241 (2008)
2. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
3. Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", Hepatology, 40, pp.1387~1395 (2004)
4. Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", J Gastroenterol Hepatol, 21, pp.138~143 (2006)
5. Fan JG, "What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?", J Gastroenterol Hepatol, 22, pp.794~800 (2007)
6. Schaffer JE, "Lipotoxicity: when tissues overeat", Curr Opin Lipidol, 14, pp.281~287 (2003)
7. Day CP, "Steatohepatitis: a tale of "two hits"?", Gastroenterology, 114, pp.842~845 (1998)
8. Feldstein AE, "Bax inhibition protects against free fatty acid-induced lysosomal permeabilization", Am J Physiol Gastrointest Liver Physiol, 290, pp.G1339~G1346 (2006)
9. Hamaguchi M, "The metabolic syndrome as a predictor of nonalcoholic fatty liver disease", Ann Intern Med, 143, pp.722~728 (2005)
10. 김병운, "만성간염 3,136례에 대한 임상분석과 生肝健脾湯의 치료효과", 대한한의학회지, 14(1), pp.216~223 (1993)
11. 김재용, "生肝健脾湯이 HepG2 cell의 증식, 세포사멸 및 활성조절 신호전달계에 미치는 영향", 대한한방내과학회지, 27(1), pp.149~165 (2006), 대한한방내과학회
12. 정성충, "흰쥐의 實驗的 動脈硬化症에 對한 生肝健脾湯의 효과", 경희한의대논문집, 14, pp.53~84 (1991)
13. 김호철, "한약약리학", pp.239~241 (2001), 집문당
14. 서부일, "고지방 식이로 유도된 비만 흰쥐에 茵蔯, 枳實, 山？가 미치는 영향", 대한본초학회지, 21(3), pp.55~67 (2006), 대한본초학회
15. Lee HS, "Hepatoprotective effects of Artemisiae Capillaris Herba and Picrorrhiza Rhizoma combinations on carbon tetrachloride-induced subacute liver damage in rats", Nutr Res, 28, pp.270~277 (2008)
16. S. Niranjali Devaraj, "Liver Architecture Maintenance by Tincture of Crataegus Against Isoproterenol-Induced Myocardially Infarcted Rats", Journal of Medicinal Food, 8(3), pp.400~404 (2005), 한국식품영양과학회
17. 이장천, "택사농축액이 고지방식이를 급여한 흰쥐의 지질구성 및 TBARS량에 미치는 영향", 대한본초학회지, 23(3), pp.113~117 (2008), 대한본초학회
18. Jong Moon Hur, "Effects of Methanol Extract of Alisma orientale Rhizome and its Major Component, Alisol B 23-acetate, on Hepatic Drug Metabolizing Enzymes in Rats Treated with Bromobenzene", Archives of Pharmacal Research, 30(12), pp.1543~1549 (2007), 대한약학회
19. 최석영, "복령 추출물이 혈중 지질성상에 미치는 영향", 한국식품영양과학회지, 35(8), pp.1005~1009 (2006), 한국식품영양과학회
20. 명성하, "竹茹와 蘿蔔子가 實驗的 糖尿에 미치는 영향", 대한본초학회지, 14(1), pp.79~86 (1999)
21. Jong Rok Lee, "Anti-obese and Hypolipemic Effects of the Aqueous Extracts of Raphani Semen in Mice Fed High Fat Diet", Journal of the Korean Society for Applied Biological Chemistry, 52(1), pp.50~57 (2009), 한국응용생명화학회
22. Borchardt RA, "Intrahepatic assembly of very low density lipoproteins", J Biol Chem, 262, pp.16394~16402 (1987)
23. Maedler K, "Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function", Diabetes, 50, pp.69~76 (2001)
24. Wei Y, "Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells", Am J Physiol Endocrinol Metab, 291, pp.E275~E281 (2006)
25. Angelico F, "Drugs improving insulin resistance for non-alcoholic fatty liver disease and", or non-alcoholic steatohepatitis, 2007, pp.(1), CD005166~
26. Krsnoff JB, "Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease", Hepatology, 47, pp.1158~1166 (2008)
27. Rallidis LS, "Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study", Atherosclerosis, 174, pp.193~196 (2004)
28. Wu X, "Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways", Hepatology, 47, pp.1905~1915 (2008)
29. 성경화, "HepG2 cell에서 Palmitic acid로 유발된 Lipotoxicity에 대한 대추(Zizyphus jujuba)의 보호효과", 박사, 한의학, pp.2010
30. Joshi-Barve S, "Palmitatic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes", Hepatology, 46, pp.823~830 (2007)
31. Gómez-Lechín MJ, "A human hepatocellular in vitro model to investigate steatosis", Chem Biol Interact, 165, pp.106~116 (2007)
32. Sanyal AJ, "Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease", Nat Clin Pract Gastroenterol Hepatol, 2, pp.46~53 (2005)
33. Robertson G, "Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress", Am J Physiol Gastrointest Liver Physiol, 281, pp.G1135~G1139 (2001)
34. Fernandez-Checa JC, "Hepatic mitochondrial glutathione: transport and role in disease and toxicity", Toxicol Appl Pharmacol, 204, pp.263~273 (2005)
35. Miura T, "Antioxidant activity of metallothionein compared with reduced glutathione", Life Sci, 60, pp.301~309 (1997)
36. Schrauwen P, "Mitochondrial dysfunction and lipotoxicity", Biochem Biophys Acta, 1801, pp.266~271 (2010)
37. Li Z, "The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity", Hepatology, 47, pp.1495~1503 (2008)
38. Almaguel FG, "Lipotoxicity-mediated cell dysfunction and death involve lysosomal membrane permeabilization and cathepsin L activity", Brain Res, 1318, pp.133~143 (2010)

관련 논문AI추천